Oncology is such a crucial segment of the pharmaceutical world. With it dominating investment and...
Techspert's Milestone Achievement in the Financial Times 1000 List
Techspert's recognition as the 539th placement in the Financial Times 1000: Europe’s Fastest Growing Companies underscores our commitment to revolutionizing how expert insights are accessed and applied in the healthcare and life sciences sectors....
Read moreHarri Lamden:
When it comes to engaging experts for primary research, there are different formats you can choose...
Not too long ago, a life sciences consultancy asked us to connect them with cannabis industry...
Nonalcoholic steatohepatitis (NASH) is a complicated liver disease without any approved...
As a Senior Associate at Techspert, I ensure customers connect to the right experts using our AI...
Expert insight enables organisations to make more informed decisions leading to increased success...
Finding new voices for your market research
